Efficacy and safety of ipilimumab induction and maintenance dosing in patients with advanced melanoma who progressed on one or more prior therapies
暂无分享,去创建一个
H. Pehamberger | V. Chiarion-Sileni | M. Maio | S. O’Day | T. Gajewski | A. Hoos | R. Ibrahim | R. Humphrey | V. DePril | J. Wolchock | S. O'Day